P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808
- Citation:
- Blood vol 116 (9) 1413-1421
- Year:
- 2010
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 461
- Children:
- None
- Pharmas:
- Grants:
- U10 CA032291, CA33601, U10 CA077658, CA02599, CA32291, CA41287, U10 CA035279, CA03927, U10 CA031946, U10 CA033601, CA35279, U10 CA077440, CA77440, U10 CA041287, U10 CA047559, CA47559, CA77658, CA31983, CA31946, U10 CA003927
- Corr. Author:
- Authors:
- Jonathan E. Kolitz Stephen L. George Guido Marcucci Ravi Vij Bayard L. Powell Steven L. Allen Daniel J. DeAngelo Thomas C. Shea Wendy Stock Maria R. Baer Vera Hars Kati Maharry Eva Hoke James W. Vardiman Clara D. Bloomfield Richard A. Larson
- Networks:
- Study
- CALGB-19808
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-8461
- Phases:
- 3, N/A
- Keywords:
- Clinical Trials and Observations